Last reviewed · How we verify

NCT03985098: MI

Motivational Interviewing (MI) Intervention to Improve Adherence

Completed NA Results posted Last updated 15 June 2023
What this trial tests

NA trial testing Motivational interviewing intervention arm in Diabetes Mellitus, Type 2 in 727 participants. Completed in 22 March 2022.

Timeline
29 May 2019
Primary endpoint
22 March 2021
22 March 2022

Quick facts

Lead sponsorUniversity of Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment727
Start date29 May 2019
Primary completion22 March 2021
Estimated completion22 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Houston

Who can join

65 and older, any sex, with Diabetes Mellitus, Type 2 or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Adherence Measure Primary · 12 months following initial call

Proportion of days covered (PDC): measured by examining refill data, both as a continuous measure as well as a categorical measure with a PDC of 0.8 or more considered adherent. It ranges from 0-1.

GroupValue95% CI
Motivational Interviewing Intervention Arm0.63± 0.34
Control0.56± 0.35

Sponsor's own description

The purpose of this study is to examine the effectiveness of a telephone motivational interviewing intervention by pharmacy students in enhancing adherence to angiotensin converting enzyme inhibitors (ACEI)/ angiotensin receptor blockers (ARB) (ACE/ARBs) among patients with diabetes and hypertension in a Medicare advantage plan.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes.
    Mohan A, Majd Z, Johnson ML, Essien EJ, et al · · 2023 · cited 16× · PMID 36847995 · DOI 10.1007/s40266-023-01008-6

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

Other University of Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03985098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing